ANIP R&D Expenses
Ani Pharmaceuticals Inc · R&D Expenses
ANIP R&D Expenses
Latest reported$14.75Mperiod ending
ANIP Quarterly R&D Expenses ($145.51K → $14.75M)
Quarterly R&D Expenses
High-resolution chart · PNG
ANIP r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 14,747,000 | |
| 10,600,000 | |
| 12,261,000 | |
| 12,304,000 | |
| 16,535,000 | |
| 10,564,000 | |
| 16,646,000 | |
| 10,128,000 | |
| 7,296,000 | |
| 10,511,000 | |
| 9,867,000 | |
| 11,121,000 | |
| 7,374,000 | |
| 5,924,000 | |
| 5,222,000 | |
| 7,657,000 | |
| 4,165,000 | |
| 5,274,000 | |
| 3,140,000 | |
| 2,456,000 | |
| 2,805,000 | |
| 2,968,000 | |
| 3,683,000 | |
| 2,939,000 | |
| 3,035,000 | |
| 6,344,000 | |
| 4,678,000 | |
| 4,982,000 | |
| 5,773,000 | |
| 4,373,000 | |
| 3,482,000 | |
| 4,667,000 | |
| 5,137,000 | |
| 2,102,000 | |
| 2,651,000 | |
| 2,634,000 | |
| 2,167,000 | |
| 1,618,000 | |
| 135,000 | |
| 1,041,000 | |
| 764,000 | |
| 966,000 | |
| 661,000 | |
| 815,000 | |
| 995,000 | |
| 403,000 | |
| 568,000 | |
| 883,000 | |
| 851,000 | |
| 376,000 | |
| 524,000 | |
| 453,897 | |
| 437,184 | |
| 972,049 | |
| 2,434,591 | |
| 3,872,736 | |
| 5,398,305 | |
| 5,183,217 | |
| 6,701,387 | |
| 11,500,053 | |
| 11,116,323 | |
| 14,864,420 | |
| 11,904,935 | |
| 9,716,091 | |
| 8,657,606 | |
| 9,426,870 | |
| 3,743,540 | |
| 3,371,217 | |
| 3,493,576 | |
| 3,072,240 | |
| 3,855,444 | |
| 5,322,472 | |
| 3,934,118 | |
| 2,677,946 | |
| 1,212,232 | |
| 1,145,764 | |
| 1,347,361 | |
| 913,852 | |
| 955,603 | |
| 766,592 | |
| 1,114,588 | |
| 1,018,877 | |
| 1,015,228 | |
| 1,314,283 | |
| 1,927,890 | |
| 2,151,679 | |
| 3,389,681 | |
| 2,450,486 | |
| 1,865,749 | |
| 1,456,523 | |
| 988,938 | |
| 960,205 | |
| 939,124 | |
| 803,153 | |
| 1,828,340 | |
| 1,326,556 | |
| 987,528 | |
| 644,394 | |
| 802,587 | |
| 719,132 |